Tivic Health Systems, Inc. Common Stock

TIVC XNAS • ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

Short interest (Apr 15)

2.2%

Net Short (Apr 27 ): -0.6%

Borrow Fee

14.99%

Available Shares

90K

Price Chart

Company Overview

Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.

Company Info

Exchange: NASDAQ

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CIK: 0001787740

Asset Type: CS

Market Data

Market Cap: $4,029,096

Employees: 52

Status: Active

Short Interest

Current Borrow Fee 14.99%

Range: 14.99% - 15.01%

Available Shares 90K

Range: 85K - 200K

Recent Changes

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime